Mangold Insight Interviews Biosergen

23 September 2022 - 14:57
Mangold Insight interviews Peder M. Andersen, CEO at Biosergen. Peder Andersen talks about the companies lead project BSG005 and the upcoming rights issue....
Nasdaq First North GM Stockholm (Sweden)
Biosergen AS
Biosergen is a biotech company developing innovative antifungal drugs based on latest biopharmaceutical research and development from laboratory facilities in Trondheim, Norway and several other places worldwide....
Learn more about company

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More